Phase II: Pembrolizumab/Carboplatin/Taxol in Epithelial Ovary Cancer
Clinical trial NCT02766582 · COMPLETED
Trial details
- NCT number
- NCT02766582
- Sponsor
- Medical College of Wisconsin
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2022-05-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.